MILLENNIUM NEWSROOM
Category
Alembic Pharmaceuticals has received final USFDA approval for its generic Oseltamivir Phosphate Oral Suspension, a therapeutic equivalent of Tamiflu, strengthening its anti-infective portfolio in the United States.
Doctors at HCG Manavata Cancer Centre in Nashik successfully removed a rare cancer from the Inferior Vena Cava through a highly complex surgery, with the 52-year-old patient walking within three days and discharged on the fifth day.
India is one of the world's largest producers of generic medicines, yet millions still struggle with high healthcare costs. Understanding the difference between branded and generic drugs helps explain why affordable healthcare remains a challenge.
The Andhra Pradesh government and Evidence Action convened a state-level conclave in Vijayawada to accelerate the scale-up of In-Line Chlorination systems and strengthen safe drinking water access under Jal Jeevan Mission 2.0.
Discover how Ayurveda medicine helps combat modern health challenges through natural remedies, balanced nutrition, stress management, and holistic wellness practices.
Zydus Therapeutics has received Priority Review from the US FDA for its New Drug Application for saroglitazar in Primary Biliary Cholangitis, with a PDUFA target action date of November 27, 2026.
P. D. Hinduja Hospital & Medical Research Centre unveiled a public awareness installation titled ‘Quit to Live’ in Mumbai to highlight the harmful effects of tobacco consumption and promote lung health awareness.
A 63-year-old patient from Palghar was successfully treated at HCG Manavata Cancer Centre after a severe airway obstruction caused by laryngeal cancer left him struggling to breathe and at risk of cardiac arrest.
P. D. Hinduja Hospital introduces the advanced CORI Surgical System for robotic-assisted knee and hip replacement surgeries across its Mahim and Khar units in Mumbai.